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Summary 
Two groups of trypsin-plasmin inhibitors were isolated 
from commercially available "Hirudin" samples, extracts 
of the leech Hirudo medicinalis. The trypsin-plasmin 
inhibitors, named Bdellins*, were separated from the 
thrombin-specific inhibitor, named Hirudin, by chroma-
tography (stepwise elution) on DEAE-cellulose. The 
Bdellins were further purified by affinity chromatography 
using trypsin resins and subsequently separated into 
two inhibitor fractions, named Bdellin A and B, by 
stepwise elution from DEAE-cellulose. Each fraction 
was separated into several components by equilibrium 
chromatography on DEAE-cellulose. 
The amino acid compositions of the Bdellin-A inhibitors 
(Table 3) differ significantly from those of the Bdellin-B 
inhibitors (Table 4), whereas the amino acid values 
obtained for the different A (Fig. 1) and B (Fig. 2) 
components are partly very similar. The inhibitors form 
1:1 complexes with bovine trypsin and porcine plasmin; 
the titration curves are shown in Figures 4 and 5. Some 
physiological and medical problems concerning the 
Bdellins are discussed. 
Introduction 
MARKWARDT et al. [1] and DE LA LLOSA et al. [2] 
isolated a thrombin-specific inhibitor from sali-
vary glands of the leech Hirudo medicinalis. 
The polypeptide nature of this inhibitor, named 
* This name was suggested by R. M A R X , Munich. 
Hirudin, has been well established by these 
authors; its molecular weight is near 10,000. 
Commercially available samples of Hirudin con-
tain, in addition to the thrombin-specific in-
hibitor, appreciable amounts of trypsin-plasmin 
inhibitors [3]. The purification, the amino acid 
compositions, and some of the inhibitory 
characteristics of these inhibitors are presented 
in this paper. 
Methods and Results 
Determination of Enzyme Act iv i t y and 
Enzyme Inhibi t ion 
The procedures described in the foregoing paper 
[4] were used for determination of the activity 
of bovine trypsin, bovine a-chymotrypsin, 
porcine plasmin, and subtilisin Novo as well 
as enzyme inhibition. The enzyme samples 
employed were also identical with the ones 
described [4]. The following substrates were 
Abbreviations: Ac, acetate; D E A E , diethylamino 
ethyl; E M A , ethylene maleic acid copolymer; T R A , 
triethanolamine. IU (inhibition unit): 1 IU causes the 
reduction of substrate hydrolysis by lju mole per minute; 
cf. réf. [4]. 
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used: Na-Benzoyl-DL-arginine p-nitxoanilide for 
trypsin and plasmin, N-3-(carboxypropionyl)-L-
phenylalanine p-nitroanilide for chymotrypsin. 
Inhibition equilibrium was achieved at every 
degree of inhibition within the preincubation 
(enzyme plus inhibitor) period used (5 minutes, 
cf. Fig. 4 and 5). 
Isolation Procedures and Properties 
Separation of the Trypsin- Plasmin Inhibitors from 
Hirudin: DEAE-cellulose (acetate-form) col-
umns, 4.2 X 44 cm, equilibrated and developed 
with 0.2M sodium acetate, pH 6.0, at 60 ml per 
hour were employed. 4.5 g "Hirudin" from 
Medimpex, Budapest, 270 A T E (anti thrombin 
units) and 0.9—1.0 IU (trypsin inhibition, cf. 
réf. [4]) per mg, dissolved in 6 ml of the elution 
buffer, were applied to each column. In three 
typical runs 94—95% of the trypsin-inhibiting 
activity applied were eluted in the inhibitor-
containing fractions in a total buffer volume of 
1.0—1.2/. 
Subsequendy the thrombin inhibitor, which is 
completely retained on the cellulose under the 
conditions employed, was eluted using a linear 
gradient formed from 2.0 liters each of the 
starting buffer and 0.6M NaCl, 0.6M sodium 
acetate, pH 6.0. 74% of the inhibitory activity 
applied were recovered. 
The trypsin-plasmin inhibitor fractions obtained 
from three column runs were combined and 
concentrated in vacuo until precipitation of 
salts started. The main portion of the salts was 
separated by dialysis for A—5 hours against 
deionized water; afterwards concentration was 
continued, followed by dialysis as soon as salt 
crystals were formed. Thus a final concentration 
of 25 IU per ml was attained (total yield: 12,500 
IU in 500 ml). Aliquots were diluted with 0.2M 
TRA-HC1, pH 7.8, to get the concentration 
desired for the trypsin-resin step. 
Affinity Chromatography Using Water-Insoluble 
Trypsin Resins: The polyamphoteric trypsin 
EMA-resin applied was synthesized starting 
from 10 g trypsin according to the method 
given in ref. [5]. The isolation procedure 
described below was repeated four times using 
this same resin. 
The trypsin resin was suspended in 70 ml of the 
trypsin-plasmin inhibitor solution containing 
1000 IU (cf. the foregoing paragraph). The 
chilled (0—4°C) mixture was vigorously stirred 
for 60—120 minutes, followed by centrifugation. 
Calculated from the inhibitory activities in the 
supernatants, amounts of inhibitors corre-
sponding to 910 up to 960 IU were bound to the 
trypsin resin. The insoluble complex was washed 
free from contaminating material by repeated 
suspension in chilled 0.2M TRA-HC1, pH 7.8 
(cf. ref. [5]). 
For dissociation the complex was suspended in 
80—95 ml chilled 0.2M KC1-HC1, pH 2.0, for 
60—90 minutes, followed by centrifugation. 
The supernatants contained 61—68% of the 
inhibitors bound to the resin. This procedure 
repeated yielded in each case another 8% of the 
bound inhibitor so that the overall recoveries 
amounted to 69—76%. 
The combined acidic inhibitor solutions were 
adjusted to pH 6.0, concentrated by evaporation 
in vacuo, and desalted by gel filtration. Using 
Sephadex G-50 columns, equilibrated and 
developed with 0.02M ammonium acetate, 
pH 6.0, 82% of the inhibitory activity applied 
was found in the eluted inhibitor fractions; 
using Biogel P-2 columns, equilibrated and 
developed with 0.01M acetic acid, 83—88% of the 
inhibitory activities applied were recovered. 
The inhibitor-containing fractions were lyo-
philized. For the material thus obtained the 
following specific activities were found: 3.5—3.8 
IU per mg using Biogel and 2.7—2.9 IU per mg 
using Sephadex. In the latter case the ammonium 
acetate was not sublimed off quantitatively 
during lyophilisation. 
Recently, we repeated this isolation step applying 
10 g of the trypsin-cellulose resin ("bovine 
trypsin polymer bound to CM-cellulose, 7—10 
U/mg") from Merck A G , Darmstadt. The resin 
was suspended for 20 minutes in about 400 ml 
chilled 0.5M NaCl, 0.05M TRA-HC1, pH 7.8, 
containing 790—1070 IU of the trypsin-plasmin 
inhibitors. For separation of contaminations the 
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In each run 45% of the inhibitory activity applied 
were retained on the DEAE-cellulose column. 
These inhibitors, named Bdellin B, were subse-
quently eluted with 0.1M sodium acetate, 0.4M 
NaCl, pH 6.0, in a total volume of 170—240 m/. 
Cf. Table 2. 
The inhibitor-containing fractions were con-
centrated by evaporation in vacuo or by ultra-
filtration and desalted using Sephadex G-25 
columns, equilibrated and developed with aque-
ous acetic acid (5%, V/V). The inhibitor 
fractions eluted (yields: 80—90% of the in-
hibitory activities applied) were lyophilized. 
The following specific activities were found: 
3.3—3.5IU/mg for Bdellin fraction A and 
4.2-^.8 IU/mg for Bdellin fraction B. 
Equilibrium Chromatography of Bdellin Fraction A : 
The DEAE-cellulose (OHh-form) columns 
(1.2 X 24 cm) employed were equilibrated and 
developed with 0.05M ammonium acetate, 
pH 6.3, at 6.5 ml per hour. 30 mg of Bdellin 
fraction A , dissolved in 1—2 ml of the elution 
buffer, were applied to each column. The 
distribution of the inhibitory activity among the 
fractions eluted is shown in Table 1, the elution 
diagram in Figure 1. Yields are given in Table 2. 
Equilibrium chromatography was repeated with 
the desalted (by repeated ultrafiltration) fractions 
2, 3, and 4 shown in Figure 1 in separate runs 
using the same conditions. As expected from the 
form of the absorption line, fractions 2 and 3 
turned out to be identical. 
Table 1. Distribution of the Inhibitory Activity among the Bdellin Fractions obtained by Equilibrium Chromatography 
Bdellin A 
Fraction (cf. Fig. 1) 1, (la) 2,3 4 5 
% of inhibitory activity* 11—16 35—40 9—17 12—15 
Bdellin B 
Fraction (cf. Fig. 2) 1 2 3 4, 5,6 
% of inhibitory activity* 5—7 14—20 29—36 9—15 
a Related to the total inhibitory activity applied to the columns. Four columns running under identical conditions were 
evaluated. 
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insoluble complex was suspended five times in 
the mentioned 0.55M salt-buffer solution and 
afterwards one time in 0.05M NaCl, 0.005M 
TRA-HC1, pH 7.8. Dissociation of the complex 
was achieved by suspending it three times in 
300 ml chilled 1.0M KC1-HC1, pH 2.5, each time 
for 10 minutes. 82—71% of the inhibitor amount 
bound to the resin (878—526 IU) were thus 
recovered. The combined neutralized inhibitor 
solutions were desalted by repeated ultra-
filtration using Amicon cells with UM-05 
membranes or by gel filtration on Sephadex 
G-25. Specific activity of the inhibitor material 
obtained after lyophilisation: 4.2 IU per mg. 
240 IU of the Bdellins were bound from 1 g 
of the trypsin resin (sample "2851 C") from 
Röhm & Haas, Darmstadt, under the same 
conditions; 66% of it were recovered after 
dissociation. 
Separation of Bdellin Fraction A from Fraction B: 
DEAE-Cellulose (OH--form) columns, 1.6 x 60 
cm, equilibrated and developed with 0.1M 
sodium acetate, pH 6.0, at 65 ml per hour were 
employed. In 5 runs performed 350—539 mg of 
the Bdellin-A, B mixture (specific activity: 
2.7—3.8 IU per mg), dissolved in about 3 ml of 
the equilibration buffer were applied. The 
inhibitor fractions eluted with the equilibration 
buffer in a total volume of 500—600 m/amounted 
in all runs to 55% of the inhibitory activity 
applied. The inhibitors contained in these 
fractions were named Bdellin A. 
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Table 2. Isolation of the Trypsin-Pksmin Inhibitors Bdellins from Commercially Available "Hirudin" Samples 
Purification step Specific activity* 
IU/mg 
Yield* 
% 
Commercial samples 0.9—1.0 
Separation from Hirudhr (thrombin inhibitor) on DEAE-cellulose (acetate-
form): With 0.2M NaAc, p H 6.0, only the Bdellins were eluted. 
94—95 
Affinity chromatography using polyamphoteric trypsin EMA-resins 3.5—3.8* 69—76 
Separation of Bdellin fractions A and B on DEAE-cellulose (OH--form): 
Elution of Bdellin A with 0.1M NaAc, p H 6.0, 
Bdellin B with 0.1M NaAc, 0.4M NaCl, p H 6.0 
3.3—3.5 
4.2—4.8 3 «• 
Fractionation of Bdellin A and B on DEAE-cellulose (OH~-form) : 
Equilibrium chromatography of 
Bdellin A with 0.05M N H 4 Ac, p H 6.3, 
Bdellin B with 0.1M NaAc, p H 5.5 
3.8 (fractions 2,3,4) 
5.1 (fraction 3) 
75—85d 
67—73d 
a Trypsin inhibition; the values were determined of the desalted and lyophilized material. 
b Related to the inhibitory activity applied to the column or resin; loss during desalting by gel filtration and ultra-
filtration is not considered, see text. 
c Material containing some ammonium acetate (see text) : 2.7—2.9. 
d A l l fractions together, cf. Table 1. 
during this step. The inhibitors obtained after 
lyophilisation with a specific activity of 3.8 IU 
per mg were used for all further investigations. 
Equilibrium Chromatography of Bdellin Fraction B : 
50 mg of Bdellin fraction B, dissolved in 1—2 ml 
of the equilibration buffer, were applied to each 
of the DEAE-cellulose (OH~-form) columns 
(1.2 X 55 cm). The columns were equilibrated 
and developed with 0.1M sodium acetate, 
pH 5.5, at 16.5 ml per hour. After elution of 
fraction B-3 (cf. Fig. 2) the residual inhibitor 
retained was eluted from the column with 
a buffer solution of higher molarity, 0.4M NaCl, 
0.1M sodium acetate, pH 5.5. See Table 1 for 
distribution of the inhibitory activity among 
the fractions eluted and Table 2 for yields. 
After desalting equilibrium chromatography of 
Bdellin fraction B-3 was repeated under identical 
conditions. 
The inhibitor fractions eluted were concentrated 
by ultrafiltration and desalted by gel filtration as 
described above. The inhibitor B-3 obtained 
10 2 0 3 0 4 0 5 0 
T U B E N O . 2 . 7 m l / T U B E -H»» 
Fig. 1. Equilibrium Chromatography 
of Bdellin Fraction A . 
For experimental details see Methods and Results. The 
inhibition curve paralleled that of the relative absorption, 
measured at 253 nm (ordinate). 
Fraction l a (cf. Table 3 and 1) corresponds to the last 
third of fraction 1, subsequent to fraction 2. 
The inhibitor fractions thus obtained were 
desalted by repeated ultrafiltration employing 
Amicon cells with UM-05 membranes. About 
5% of the inhibitor amount applied was lost 
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after lyophilisation with a specific activity of 
5.1 IU per mg was used for further investi-
gations. 
In order to obtain enough material for sequential 
studies the isolation procedure was repeated on 
a larger scale. Fig. 3 shows the distribution of the 
inhibitory activity among the Bdellin fractions 
obtained employing inhibitors with 4.2 IU per 
mg purified with the trypsin-cellulose resin from 
Merck A G . The last fraction shown in Figure 2 
can be separated into three fractions (B-4,-5,-6) 
using a linear gradient formed from 350 ml each 
2 to-
B D E L L I N B 
' F R A C T I O N 1 * 1 4,5,6 
2 0 "T" 
3 0 
T ! 
1 16 
1 2 m l / T U B E 
5,5 m l / T U B E 
T U B E N O — • 
Fig. 2. Equilibrium Chromatography 
of Bdellin Fraction B. 
For experimental details see Methods and Results. The 
absorption of the eluate was measured at 253 nm (ordinate). 
into two fractions, A-2 and A-3, however both 
fractions turned out to be identical in their 
behaviour during chromatography and in the 
amino acid composition. 
Only the nearest integer values are given for the 
other fractions not further purified by re-
chromatography, provided that the deviations 
B D E L L I N B 
T 1 ? — 
5 0 8 0 6 0 
T U B E NO, 4 .0 m l / T U B E — 
9 0 
Fig. 3. Equilibrium and Gradient Elution Chromato-
graphy of Bdellin Fraction B. 
Experimental details are given in Methods and Results. 
The gradient was started with tube number 1. 
of the equilibration buffer (0.1M sodium acetate, 
pH 5.5) and 0.6M NaCl, 0.1M sodium acetate, 
pH 5.5 (cf. Fig. 3). By total yields of 82—84%, 
based on the inhibitory activity applied, 25—29% 
of the inhibitory activity were found in fraction 
B - l , 2, 35% in fraction B-3,11—15% in fraction 
B-4, 5, 6 and 8—10% in the intermediate 
fractions. Inhibitor B-3 is used for the sequential 
studies under investigation. 
Amino Acid Composition: The amino acid 
compositions of the different inhibitor compo-
nents separated by equilibrium chromatography 
and of the starting mixtures, Bdellin fractions A 
and B, are presented in Tables 3 and 4. The in-
hibitors obtained after rechromatography were 
applied for analysis of components A-2, 3, A-4, 
and B-3. At first, inhibitor A-2, 3 was divided 
from the values of the corresponding main 
fraction were not larger than ± 0 . 1 ; otherwise 
the values found are shown. 
The presence of carbohydrate residues and free 
sulfhydryl groups was not observed in the pure 
Bdellin fractions. Only about 91% of the cystine 
content of the Bdellins were recovered as cysteic 
acid after performic acid oxidation; some 
observations indicate that this is probably due 
to a small contamination of non-protein character 
which influences the oxidation reaction. 
The inhibitor molecule of Bdellin B-3 contains 
no residue of the following amino acids : proline, 
methionine, isoleucine, phenylalanine, and tryp-
tophan. For complete release of valine and 
lysine from the Bdellin-A fractions a longer 
hydrolysis time (70 hours) was necessary. 
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Table 3. Amino Acid Compositions of Bdellin-A Fractions 
Bdellin-A: Mixture of inhibitors used as starting material for separation by equilibrium chromatography (cf. Fig. 1). 
Bdellin A-1, A-1 a (cf. legend of Fig. 1): Only the values deviating from the corresponding ones of inhibitor A-2,3 
are given. 
Bdellin A-2t 3 and A-4: The inhibitors obtained after rechromatography were used for analysis 
Bdellin fraction 
Hours hydrolyzed 
A 
20 
A-1 
20, 70 
A-1 a 
20,70 
A-2,3 A-4 
20 70 Integer 21 70 Integer 
Cysteic acid 9.10a (10) 9.16» (10) 
Methionine sulfone 0.81» (1) 0.95» (1) 
Aspartic acid 7.19 6 6 7.85 7.98 8 7.17 7.24 7 
Threonine 3.01 2.6 3.01 2.88 3 2.91 2.82 3 
Serine 2.97 3.06 2.64 3 2.90 2.77 3 
Glutamic acid 6.45 6 6 5.18 5.27 5 5.04 5.06 5 
Proline 2.80 2.3 2 2.95 2.73 3 2.76 2.74 3 
Glycine 4.73 5 5 4.19 4.00 4 4.11 3.96 4 
Alanine 3.96 3 3.98 3.96 4 3.83 3.88 4 
Half-cystine 9.41 9.14 8.56 10 7.87 3.68 10 
Valine 4.19* 3.4 4 4.61 4.95 5 4.35 4.89 5 
Methionine 0.42 0.62 0.68 1 0.66 0.48 1 
Isoleucine 1.01* 0.87 1.07 1 0.94 1.03 1 
Leucine 1.58 2 2 1.19 1.12 1 1.14 1.12 1 
Tyrosine 1.21 0.94 0.86 1 0.88 0.77 1 
Phenylalanine 1.95 1 1.88 1.77 2 1.67 1.80 2 
Lysine 4.82* 3 3 4.58 4.96 5 4.35 4.78 5 
Histidine 2.80 2 2.95 2.94 3 2.93 2.83 3 
Arginine 1.05 1.6 1 0.17 0.13 0 0.17 0.19 0 
Tryptophan0 0.12 0.12 0 0 
Total 
Molecular weightd 
56 
5965 
59 
6339 
58 
6224 
» After performic acid oxidation, 
b Value from 70 hours hydrolysate, 
c Spectrophotometric determination [7], 
d Degree of amidation is not considered. 
Molecular Weight'. The molecular weights calcu-
lated from the amino acid compositions (cf. 
Tab. 3 and 4) are in good agreement with the 
values obtained by gel filtration experiments. 
Using Sephadex G-75 columns, equilibrated and 
developed with 0.15M NaCl, 0.05M citric acid, 
pH 2.5, at 17 ml per hour, the molecular weight 
found for Bdellin A (mixture) amounted to 
7000, for Bdellin B (mixture) to 5600. From 
the specific activities similar values are calcula-
ted. 
Inhibitory Characteristics: Both Bdellin groups A 
and B are strong inhibitors for bovine trypsin 
and porcine plasmin. The titration curves with 
Bdellin A-4 and Bdellin B-3 are shown in 
Figure 4 and Figure 5 respectively. In each case 
one enzyme molecule reacts with one inhibitor 
molecule to form the complex. No differences 
were observed applying the other Bdellin frac-
tions in the titration experiments. 
In both Bdellin groups lysine residues are located 
in the reactive site of the inhibitors : More than 
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Table 4. Amino Acid Compositions of Bdellin-B Fractions 
Bdellin-B: Mixture of inhibitors used as starting material for separation by equilibrium chromatography (cf. Fig. 2). 
Bdellin B-1, B-2y B-4, 5, 6: Only the values deviating from the corresponding ones of inhibitor B-3 are given. 
Bdellin B-3: The inhibitor obtained after rechromatography was used for analysis. 
Bdellin fraction 
Hours hydrolyzed 
B 
20 
B-1 
20 
B-2 
20 20 
B-3 
70 Integer 
B-4, 5,6 
20 
Cysteic acid 5.60» (6) 
Methionine sulfone < 0 . 0 5 » (0) 
Aspartic acid 5.21 5.13 5.14 5 7 
Threonine 3.39 3 3.7 3.84 3.80 4 
Serine 1.93 2.7 1.97 1.96 2 4 
Glutamic acid 5.81 5 5.93 6.02 6 8 
Proline 0.60 1.4 1 <0.05 <0.05 0 1 
Glycine 3.71 4.10 4.10 4 
Alanine 3.42 3.5 3.92 3.92 4 
Half-cystine 4.32 5.27 3.72 6 
Valine 4.08 4.09 4.17 4 
Methionine 0.19 <0.05 <0.05 0 
Isoleucine 0.19 0.3 0.16 0.09 0 0.3 
Leucine 1.69 1.6 1.98 2.10 2 
Tyrosine 0.95 0.99 0.98 1 
Phenylalanine 0.35 0.4 0.09 0.10 0 0.5 
Lysine 1.75 2 1.5 1.12 1.10 1 2 
Histidine 6.15 4.94 5.02 5* 
Arginine 1.01 0.6 1.11 0.94 1 
Tryptophan11 0.12 0.25 0 
Total 
Molecular weight0 
45 
4830 
a After performic acid oxidation, * In Bdellin B-3, isolated recently (Fig. 3), 5.80 His were 
b Spectrophotometry determination [7], found. His may be destroyed to some extent during 
c Degree of amidation is not considered. storage (cf. this volume, p. 228, Table 3, footnote c). 
96% of the inhibitory activity against trypsin and 
plasmin are lost during maleylation [8]. The in-
hibitory activity is restored by deacylation in 
acidic solution [8]. The inhibitors are modified 
(reactive site bond split) to a smaller extent: 
The Bdellin fractions A , A-4, B, and B-3 lose 
15—20% of their inhibitory activity during 
incubation with carboxypeptidase B under the 
following conditions : 0.3 mg inhibitor and 
0.05 mg carboxypeptidase B in 0.43 ml TRIS-
HC1, pH 8.0, 25° C, 29 hours (and 53 hours). 
The modification reaction occurs probably 
during contact with the trypsin resin [6]. In gel 
filtration experiments the formation of ternary 
complexes was not observed. 
The following proteinases are not inhibited by 
the Bdellins: Porcine pancreatic kallikrein, 
bovine öc-chymotrypsin, and subtilisin Novo. 
However, the commercial Hirudin samples 
contain about 25 mg (assuming a molecular 
weight near 6000) of an inhibitor for bovine 
a-chymotrypsin. Small amounts of this inhibitor 
are still determinable in both Bdellin mixtures, 
2% by weight in Bdellin B and 5% in Bdellin A . 
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Ss 
B D E L U N A 
FRACTION 4 
TRYPSIN I N H i a 
.PLASMIN INHIB. \ 
"^7 
T R Y P S M INHIB. 1 
PLASMIN INHIB. 10 
! 
2 
2 0 
INHIBITOR, p g 
—»— 
3 
3 0 
— r 
4 
4 0 
Fig. 4. Titration of Bovine Trypsin and Porcine Plasmin 
with Bdellin-A. 
Bdellin fraction A-4 (cf. Fig. 1 and Table 3) with a 
specific activity of 3.8 IU (trypsin inhibition) per mg 
was used. Details of the procedure are presented in the 
foregoing paper [4] in Methods and in the legends of 
Figures 5 and 6. 
1) Titration of Trypsin: Constant amounts of trypsin, 
0.39 n mole titrated [4], were incubated with increasing 
amounts of the inhibitor in 2.0 ml 0.2M TRA-HC1, p H 
7.8, for 5 minutes at 25° C. The enzymatic reaction was 
started by addition of 1.0 ml of the substrate solution. 
Measured at 94% inhibition, the degree of inhibition was 
constant using preincubation periods from 5 up to 
15 minutes. 
2) Titration of Plasmin: Constant amounts of plasmin, 
2.5 n mole titrated [4], were incubated with increasing 
amounts of the inhibitor in 2.0 ml 0.2M TRA-HC1, 
0.05M L-lysine, p H 7.8, for 5 minutes at 25° C. The 
enzymatic reaction was started by addition of 1.0 ml of 
the substrate solution. 
Discussion 
Purification 
A series of purification steps was necessary to 
obtain the trypsin-plasmin inhibitors Bdellins 
in highly purified form from commercially 
available "Hirudin" samples. 
One gram of the starting material from Med-
impex (270 A T E per mg) contains about 230 mg 
V 
3 c 
B D E L L I N B 
FRACTION 3 
\ 
\ 
\ J T R Y P S I N I N H I B . 
' N ^ P L A S M I N I N H I B . 
T R Y P S I N INHIB. 
P L A S M I N INHIB. 
INHIBITOR, p g 
- ~ r -
1 
10 
T — 
2 
2 0 
Fig. 5. Titration of Bovine Trypsin and Porcine Plasmin 
with Bdellin-B. 
Bdellin fraction B-3 (cf. Fig. 2 and Table 4) with a 
specific activity of 5.1 IU (trypsin inhibition) per mg was 
used. Details of the procedure are presented in the fore-
going paper [4] in Methods and in the legends of Fig. 5 
and 6; cf. legende of Fig. 4. 
1) Titration of Trypsin: Constant amounts of trypsin, 
0.41 n mole titrated [4], were incubated with increasing 
amounts of the inhibitor in 2.0 ml 0.2M TRA-HC1, 
p H 7.8, for 5 minutes at 25° C. The enzymatic reaction 
was started by addition of 1.0 ml of the substrate solution. 
2) Titration of Plasmin: Constant amounts of plasmin, 
2.6 n mole titrated [4], were incubated with increasing 
amounts of the inhibitor in 2.0 ml 0.2M TRA-HC1, 
0.05M L-lysine, p H 7.8, for 5 minutes at 25° C. The 
enzymatic reaction was started by addition of 1.0 ml 
of the substrate solution. 
of the Bdellins and only 27 mg of the thrombin 
inhibitor Hirudin. This proportion to the 
disadvantage of Hirudin is probably the reason 
why the Bdellins were not easily separated 
during purification of Hirudin: We calculated 
from the results of our measurements (trypsin 
inhibition, electrophoresis) that one gram of the 
sterile "Hirudin" samples from Serva (3400 
A T E per mg) contains, besides 300 mg Hirudin, 
still about 75 mg of the Bdellin-A, B mixture. 
The purest Hirudin samples isolated by M A R K -
WARDT et al. [1] are free of Bdellins [3]. 
Separation of Bdellins and Hirudin is easily and 
completely achieved with satisfying yields by 
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stepwise elution of the inhibitors from the 
acetate form of DEAE-cellulose. The recovery of 
Hirudin is much lower if the OH~-form of 
DEAE-cellulose is employed. The Hirudin thus 
obtained was separated by gradient elution 
chromatography into four fractions, two main 
and two smaller fractions; the conditions used 
are described elsewhere. 
The purification of the Bdellins is decisively 
simplified by the trypsin resin step. Many 
attemps to obtain pure Bdellins using only ion 
exchange chromatography were not successful. 
The recoveries obtained with the two differ-
ent resins employed were similar, however, 
the specific activity of the Bdellins isolated with 
the trypsin-cellulose resin was higher (4.2 IU 
per mg instead of 3.5—3.8 IU per mg using 
a polyamphoteric EMA-resin). Probably this 
is due to reduction of unspecific adsorption by 
the cellulose carrier and to the use of 1.0M salt-
buffer solutions for the binding and washing 
steps. If the complex was dissociated at pH 2 
(EMA-resin), only two extractions were neces-
sary, whereas at pH 2.5 (cellulose resin) some 
more extractions were made. In this case 63, 12, 
4, and 1% of the bound inhibitors were re-
covered. 
Loss of inhibitory activity was very low (only 
about 5%) during desalting of the inhibitor 
solutions by repeated (4—5 times) ultrafiltration 
in Amicon cells fitted with UM-05 membranes. 
The only disadvantage is that small soluble 
portions of the resin and of DEAE-cellulose are 
not separated during this procedure so that 
subsequent gel filtration may be necessary. 
Mult ip le Inhibitor Forms 
Both Bdellin groups A and B contain a relative 
high amount of disulfide bridges, a finding 
which is common to most of the proteinase 
inhibitors known till now [9], The high content 
of histidine residues in the Bdellins is also 
remarkable. On the other hand, the amino acid 
compositions of the A-components (Table 3) 
are so different from those of the B-components 
that obviously no genetic relationship exists 
between the Bdellin components A and B. 
However, the differences within both inhibitor 
groups may be caused by enzymatic degradation 
during storage of perished animals and the first 
isolation steps; but also the synthesis of some-
what different components by mutated gens is 
possible [10]. It was expected that the number of 
bonds hydrolyzed during contact with the 
trypsin resin should be very small [11]. 
The isolation of at least four different compo-
nents of the thrombin inhibitor may be ex-
plained in the same way. 
The sequence of Bdellin B-3 is now under in-
vestigation. To our knowledge this is the first 
proteinase inhibitor which contains no proline 
residue [12], It is noteworthy that lack of iso-
leucine, methionine, phenylalanine, and trypto-
phan is observed in this inhibitor. The only 
lysine residue present in Bdellin B-3 is located 
in the reactive site [8]. Therefore, the influence 
of chemical modification of this residue on 
trypsin and plasmin inhibition can be uniquely 
assigned. 
Bdellin B-3 is the smallest naturally occuring 
inhibitor for trypsin and plasmin found until 
now. The inhomogeneity of Bdellin fraction B-3 
shown in Figures 2 and 3 (shoulder in the right 
part of the peak !) is caused by modified inhibitor 
forms in which peptide bonds within the mole-
cule are split without loss of the inhibitory 
activity. 
Physiological and Medical Problems 
The Bdellins occur in all zones of the body of the 
leech, but the highest concentration is found in 
the region of the outer sexual organs [13]. 
We assume therefore that the function of these 
inhibitors has to be seen in connection with 
the trypsin-plasmin inhibitors found in seminal 
vesicles and seminal plasma of many animals and 
of man [14, 15], The Bdellins are strong 
inhibitors of the plasmin-like activity occurring 
in human sperm plasma [13]. Certainly, the 
Bdellins will also inhibit the trypsin-like pro-
teinase isolated from rabbit sperms by Z A N E VELD 
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et al. [15] which has an important function in 
fertilization. 
The possible use of Bdellin-A in medical therapy 
(concerning plasmin inhibition) is under in-
vestigation [13]. An advantage may be the 
secretion of the Bdellins in the urine in contrast 
to the basic trypsin-kallikrein inhibitor which is 
stored in the kidneys shortly after intraveneous 
injection [16]. The reason why Hirudin is not 
widely used in medical therapy is perhaps caused 
by the fact that the purest samples available 
for medical use contain considerable amounts of 
the Bdellins so that both effects, thrombin in-
hibition and plasmin inhibition, supperimpose 
and thus no consistent results are obtained. 
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